Long-acting Weight Loss Drugs and Forecast - Market
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Long-acting Weight Loss Drugs
1.2 Key Market Segments
1.2.1 Long-acting Weight Loss Drugs Segment by Type
1.2.2 Long-acting Weight Loss Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Long-acting Weight Loss Drugs Market Overview
2.1 Global Market Overview
2.1.1 Global Long-acting Weight Loss Drugs Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Long-acting Weight Loss Drugs Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Long-acting Weight Loss Drugs Market Competitive Landscape
3.1 Global Long-acting Weight Loss Drugs Sales by Manufacturers (2019-2025)
3.2 Global Long-acting Weight Loss Drugs Revenue Market Share by Manufacturers (2019-2025)
3.3 Long-acting Weight Loss Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Long-acting Weight Loss Drugs Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Long-acting Weight Loss Drugs Sales Sites, Area Served, Product Type
3.6 Long-acting Weight Loss Drugs Market Competitive Situation and Trends
3.6.1 Long-acting Weight Loss Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Long-acting Weight Loss Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Long-acting Weight Loss Drugs Industry Chain Analysis
4.1 Long-acting Weight Loss Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Long-acting Weight Loss Drugs Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Long-acting Weight Loss Drugs Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Long-acting Weight Loss Drugs Sales Market Share by Type (2019-2025)
6.3 Global Long-acting Weight Loss Drugs Market Size Market Share by Type (2019-2025)
6.4 Global Long-acting Weight Loss Drugs Price by Type (2019-2025)
7 Long-acting Weight Loss Drugs Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Long-acting Weight Loss Drugs Market Sales by Application (2019-2025)
7.3 Global Long-acting Weight Loss Drugs Market Size (M USD) by Application (2019-2025)
7.4 Global Long-acting Weight Loss Drugs Sales Growth Rate by Application (2019-2025)
8 Long-acting Weight Loss Drugs Market Consumption by Region
8.1 Global Long-acting Weight Loss Drugs Sales by Region
8.1.1 Global Long-acting Weight Loss Drugs Sales by Region
8.1.2 Global Long-acting Weight Loss Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Long-acting Weight Loss Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Long-acting Weight Loss Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Long-acting Weight Loss Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Long-acting Weight Loss Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Long-acting Weight Loss Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Long-acting Weight Loss Drugs Market Production by Region
9.1 Global Production of Long-acting Weight Loss Drugs by Region (2019-2025)
9.2 Global Long-acting Weight Loss Drugs Revenue Market Share by Region (2019-2025)
9.3 Global Long-acting Weight Loss Drugs Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Long-acting Weight Loss Drugs Production
9.4.1 North America Long-acting Weight Loss Drugs Production Growth Rate (2019-2025)
9.4.2 North America Long-acting Weight Loss Drugs Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Long-acting Weight Loss Drugs Production
9.5.1 Europe Long-acting Weight Loss Drugs Production Growth Rate (2019-2025)
9.5.2 Europe Long-acting Weight Loss Drugs Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Long-acting Weight Loss Drugs Production (2019-2025)
9.6.1 Japan Long-acting Weight Loss Drugs Production Growth Rate (2019-2025)
9.6.2 Japan Long-acting Weight Loss Drugs Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Long-acting Weight Loss Drugs Production (2019-2025)
9.7.1 China Long-acting Weight Loss Drugs Production Growth Rate (2019-2025)
9.7.2 China Long-acting Weight Loss Drugs Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Novo Nordisk
10.1.1 Novo Nordisk Long-acting Weight Loss Drugs Basic Information
10.1.2 Novo Nordisk Long-acting Weight Loss Drugs Product Overview
10.1.3 Novo Nordisk Long-acting Weight Loss Drugs Product Market Performance
10.1.4 Novo Nordisk Business Overview
10.1.5 Novo Nordisk Long-acting Weight Loss Drugs SWOT Analysis
10.1.6 Novo Nordisk Recent Developments
10.2 Roche
10.2.1 Roche Long-acting Weight Loss Drugs Basic Information
10.2.2 Roche Long-acting Weight Loss Drugs Product Overview
10.2.3 Roche Long-acting Weight Loss Drugs Product Market Performance
10.2.4 Roche Business Overview
10.2.5 Roche Long-acting Weight Loss Drugs SWOT Analysis
10.2.6 Roche Recent Developments
10.3 GSK
10.3.1 GSK Long-acting Weight Loss Drugs Basic Information
10.3.2 GSK Long-acting Weight Loss Drugs Product Overview
10.3.3 GSK Long-acting Weight Loss Drugs Product Market Performance
10.3.4 GSK Long-acting Weight Loss Drugs SWOT Analysis
10.3.5 GSK Business Overview
10.3.6 GSK Recent Developments
10.4 Vivus
10.4.1 Vivus Long-acting Weight Loss Drugs Basic Information
10.4.2 Vivus Long-acting Weight Loss Drugs Product Overview
10.4.3 Vivus Long-acting Weight Loss Drugs Product Market Performance
10.4.4 Vivus Business Overview
10.4.5 Vivus Recent Developments
10.5 Arena
10.5.1 Arena Long-acting Weight Loss Drugs Basic Information
10.5.2 Arena Long-acting Weight Loss Drugs Product Overview
10.5.3 Arena Long-acting Weight Loss Drugs Product Market Performance
10.5.4 Arena Business Overview
10.5.5 Arena Recent Developments
10.6 Orexigen
10.6.1 Orexigen Long-acting Weight Loss Drugs Basic Information
10.6.2 Orexigen Long-acting Weight Loss Drugs Product Overview
10.6.3 Orexigen Long-acting Weight Loss Drugs Product Market Performance
10.6.4 Orexigen Business Overview
10.6.5 Orexigen Recent Developments
11 Long-acting Weight Loss Drugs Market Forecast by Region
11.1 Global Long-acting Weight Loss Drugs Market Size Forecast
11.2 Global Long-acting Weight Loss Drugs Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Long-acting Weight Loss Drugs Market Size Forecast by Country
11.2.3 Asia Pacific Long-acting Weight Loss Drugs Market Size Forecast by Region
11.2.4 South America Long-acting Weight Loss Drugs Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Long-acting Weight Loss Drugs by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Long-acting Weight Loss Drugs Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Long-acting Weight Loss Drugs by Type (2025-2032)
12.1.2 Global Long-acting Weight Loss Drugs Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Long-acting Weight Loss Drugs by Type (2025-2032)
12.2 Global Long-acting Weight Loss Drugs Market Forecast by Application (2025-2032)
12.2.1 Global Long-acting Weight Loss Drugs Sales (K MT) Forecast by Application
12.2.2 Global Long-acting Weight Loss Drugs Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Long-acting Weight Loss Drugs Market Size Comparison by Region (M USD)
Table 5. Global Long-acting Weight Loss Drugs Sales (K MT) by Manufacturers (2019-2025)
Table 6. Global Long-acting Weight Loss Drugs Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Long-acting Weight Loss Drugs Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Long-acting Weight Loss Drugs Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-acting Weight Loss Drugs as of 2022)
Table 10. Global Market Long-acting Weight Loss Drugs Average Price (USD/MT) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Long-acting Weight Loss Drugs Sales Sites and Area Served
Table 12. Manufacturers Long-acting Weight Loss Drugs Product Type
Table 13. Global Long-acting Weight Loss Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Long-acting Weight Loss Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Long-acting Weight Loss Drugs Market Challenges
Table 22. Global Long-acting Weight Loss Drugs Sales by Type (K MT)
Table 23. Global Long-acting Weight Loss Drugs Market Size by Type (M USD)
Table 24. Global Long-acting Weight Loss Drugs Sales (K MT) by Type (2019-2025)
Table 25. Global Long-acting Weight Loss Drugs Sales Market Share by Type (2019-2025)
Table 26. Global Long-acting Weight Loss Drugs Market Size (M USD) by Type (2019-2025)
Table 27. Global Long-acting Weight Loss Drugs Market Size Share by Type (2019-2025)
Table 28. Global Long-acting Weight Loss Drugs Price (USD/MT) by Type (2019-2025)
Table 29. Global Long-acting Weight Loss Drugs Sales (K MT) by Application
Table 30. Global Long-acting Weight Loss Drugs Market Size by Application
Table 31. Global Long-acting Weight Loss Drugs Sales by Application (2019-2025) & (K MT)
Table 32. Global Long-acting Weight Loss Drugs Sales Market Share by Application (2019-2025)
Table 33. Global Long-acting Weight Loss Drugs Sales by Application (2019-2025) & (M USD)
Table 34. Global Long-acting Weight Loss Drugs Market Share by Application (2019-2025)
Table 35. Global Long-acting Weight Loss Drugs Sales Growth Rate by Application (2019-2025)
Table 36. Global Long-acting Weight Loss Drugs Sales by Region (2019-2025) & (K MT)
Table 37. Global Long-acting Weight Loss Drugs Sales Market Share by Region (2019-2025)
Table 38. North America Long-acting Weight Loss Drugs Sales by Country (2019-2025) & (K MT)
Table 39. Europe Long-acting Weight Loss Drugs Sales by Country (2019-2025) & (K MT)
Table 40. Asia Pacific Long-acting Weight Loss Drugs Sales by Region (2019-2025) & (K MT)
Table 41. South America Long-acting Weight Loss Drugs Sales by Country (2019-2025) & (K MT)
Table 42. Middle East and Africa Long-acting Weight Loss Drugs Sales by Region (2019-2025) & (K MT)
Table 43. Global Long-acting Weight Loss Drugs Production (K MT) by Region (2019-2025)
Table 44. Global Long-acting Weight Loss Drugs Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Long-acting Weight Loss Drugs Revenue Market Share by Region (2019-2025)
Table 46. Global Long-acting Weight Loss Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 47. North America Long-acting Weight Loss Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 48. Europe Long-acting Weight Loss Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 49. Japan Long-acting Weight Loss Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 50. China Long-acting Weight Loss Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 51. Novo Nordisk Long-acting Weight Loss Drugs Basic Information
Table 52. Novo Nordisk Long-acting Weight Loss Drugs Product Overview
Table 53. Novo Nordisk Long-acting Weight Loss Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 54. Novo Nordisk Business Overview
Table 55. Novo Nordisk Long-acting Weight Loss Drugs SWOT Analysis
Table 56. Novo Nordisk Recent Developments
Table 57. Roche Long-acting Weight Loss Drugs Basic Information
Table 58. Roche Long-acting Weight Loss Drugs Product Overview
Table 59. Roche Long-acting Weight Loss Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 60. Roche Business Overview
Table 61. Roche Long-acting Weight Loss Drugs SWOT Analysis
Table 62. Roche Recent Developments
Table 63. GSK Long-acting Weight Loss Drugs Basic Information
Table 64. GSK Long-acting Weight Loss Drugs Product Overview
Table 65. GSK Long-acting Weight Loss Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 66. GSK Long-acting Weight Loss Drugs SWOT Analysis
Table 67. GSK Business Overview
Table 68. GSK Recent Developments
Table 69. Vivus Long-acting Weight Loss Drugs Basic Information
Table 70. Vivus Long-acting Weight Loss Drugs Product Overview
Table 71. Vivus Long-acting Weight Loss Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 72. Vivus Business Overview
Table 73. Vivus Recent Developments
Table 74. Arena Long-acting Weight Loss Drugs Basic Information
Table 75. Arena Long-acting Weight Loss Drugs Product Overview
Table 76. Arena Long-acting Weight Loss Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 77. Arena Business Overview
Table 78. Arena Recent Developments
Table 79. Orexigen Long-acting Weight Loss Drugs Basic Information
Table 80. Orexigen Long-acting Weight Loss Drugs Product Overview
Table 81. Orexigen Long-acting Weight Loss Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 82. Orexigen Business Overview
Table 83. Orexigen Recent Developments
Table 84. Global Long-acting Weight Loss Drugs Sales Forecast by Region (2025-2032) & (K MT)
Table 85. Global Long-acting Weight Loss Drugs Market Size Forecast by Region (2025-2032) & (M USD)
Table 86. North America Long-acting Weight Loss Drugs Sales Forecast by Country (2025-2032) & (K MT)
Table 87. North America Long-acting Weight Loss Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 88. Europe Long-acting Weight Loss Drugs Sales Forecast by Country (2025-2032) & (K MT)
Table 89. Europe Long-acting Weight Loss Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 90. Asia Pacific Long-acting Weight Loss Drugs Sales Forecast by Region (2025-2032) & (K MT)
Table 91. Asia Pacific Long-acting Weight Loss Drugs Market Size Forecast by Region (2025-2032) & (M USD)
Table 92. South America Long-acting Weight Loss Drugs Sales Forecast by Country (2025-2032) & (K MT)
Table 93. South America Long-acting Weight Loss Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 94. Middle East and Africa Long-acting Weight Loss Drugs Consumption Forecast by Country (2025-2032) & (Units)
Table 95. Middle East and Africa Long-acting Weight Loss Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 96. Global Long-acting Weight Loss Drugs Sales Forecast by Type (2025-2032) & (K MT)
Table 97. Global Long-acting Weight Loss Drugs Market Size Forecast by Type (2025-2032) & (M USD)
Table 98. Global Long-acting Weight Loss Drugs Price Forecast by Type (2025-2032) & (USD/MT)
Table 99. Global Long-acting Weight Loss Drugs Sales (K MT) Forecast by Application (2025-2032)
Table 100. Global Long-acting Weight Loss Drugs Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Long-acting Weight Loss Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Long-acting Weight Loss Drugs Market Size (M USD), 2019-2032
Figure 5. Global Long-acting Weight Loss Drugs Market Size (M USD) (2019-2032)
Figure 6. Global Long-acting Weight Loss Drugs Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Long-acting Weight Loss Drugs Market Size by Country (M USD)
Figure 11. Long-acting Weight Loss Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Long-acting Weight Loss Drugs Revenue Share by Manufacturers in 2023
Figure 13. Long-acting Weight Loss Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Long-acting Weight Loss Drugs Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Long-acting Weight Loss Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Long-acting Weight Loss Drugs Market Share by Type
Figure 18. Sales Market Share of Long-acting Weight Loss Drugs by Type (2019-2025)
Figure 19. Sales Market Share of Long-acting Weight Loss Drugs by Type in 2023
Figure 20. Market Size Share of Long-acting Weight Loss Drugs by Type (2019-2025)
Figure 21. Market Size Market Share of Long-acting Weight Loss Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Long-acting Weight Loss Drugs Market Share by Application
Figure 24. Global Long-acting Weight Loss Drugs Sales Market Share by Application (2019-2025)
Figure 25. Global Long-acting Weight Loss Drugs Sales Market Share by Application in 2023
Figure 26. Global Long-acting Weight Loss Drugs Market Share by Application (2019-2025)
Figure 27. Global Long-acting Weight Loss Drugs Market Share by Application in 2023
Figure 28. Global Long-acting Weight Loss Drugs Sales Growth Rate by Application (2019-2025)
Figure 29. Global Long-acting Weight Loss Drugs Sales Market Share by Region (2019-2025)
Figure 30. North America Long-acting Weight Loss Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 31. North America Long-acting Weight Loss Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Long-acting Weight Loss Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 33. Canada Long-acting Weight Loss Drugs Sales (K MT) and Growth Rate (2019-2025)
Figure 34. Mexico Long-acting Weight Loss Drugs Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Long-acting Weight Loss Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 36. Europe Long-acting Weight Loss Drugs Sales Market Share by Country in 2023
Figure 37. Germany Long-acting Weight Loss Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 38. France Long-acting Weight Loss Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 39. U.K. Long-acting Weight Loss Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 40. Italy Long-acting Weight Loss Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 41. Russia Long-acting Weight Loss Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 42. Asia Pacific Long-acting Weight Loss Drugs Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Long-acting Weight Loss Drugs Sales Market Share by Region in 2023
Figure 44. China Long-acting Weight Loss Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 45. Japan Long-acting Weight Loss Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 46. South Korea Long-acting Weight Loss Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 47. India Long-acting Weight Loss Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 48. Southeast Asia Long-acting Weight Loss Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 49. South America Long-acting Weight Loss Drugs Sales and Growth Rate (K MT)
Figure 50. South America Long-acting Weight Loss Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Long-acting Weight Loss Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 52. Argentina Long-acting Weight Loss Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 53. Columbia Long-acting Weight Loss Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 54. Middle East and Africa Long-acting Weight Loss Drugs Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Long-acting Weight Loss Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Long-acting Weight Loss Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 57. UAE Long-acting Weight Loss Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 58. Egypt Long-acting Weight Loss Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 59. Nigeria Long-acting Weight Loss Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 60. South Africa Long-acting Weight Loss Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 61. Global Long-acting Weight Loss Drugs Production Market Share by Region (2019-2025)
Figure 62. North America Long-acting Weight Loss Drugs Production (K MT) Growth Rate (2019-2025)
Figure 63. Europe Long-acting Weight Loss Drugs Production (K MT) Growth Rate (2019-2025)
Figure 64. Japan Long-acting Weight Loss Drugs Production (K MT) Growth Rate (2019-2025)
Figure 65. China Long-acting Weight Loss Drugs Production (K MT) Growth Rate (2019-2025)
Figure 66. Global Long-acting Weight Loss Drugs Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Long-acting Weight Loss Drugs Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Long-acting Weight Loss Drugs Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Long-acting Weight Loss Drugs Market Share Forecast by Type (2025-2032)
Figure 70. Global Long-acting Weight Loss Drugs Sales Forecast by Application (2025-2032)
Figure 71. Global Long-acting Weight Loss Drugs Market Share Forecast by Application (2025-2032)
